Eduard Gorina

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial

Luca Richeldi, Evans R. Fernández Pérez, Ulrich Costabel et al. · The Lancet Respiratory Medicine · 2019 · 286 citations

Medicine, Clinical Sciences, Pharmacotherapy +13

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial

Dinesh Khanna, Carlo Albera, Aryeh Fischer et al. · The Journal of Rheumatology · 2016 · 269 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function

Carlo Albera, Ulrich Costabel, Elizabeth A. Fagan et al. · European Respiratory Journal · 2016 · 165 citations · Full text

Health Professions, Pharmacotherapy, Pulmonary Function Testing +14

The orthopaedic status of severe haemophiliacs in Spain

José A. Aznar, M Magallón, Felipe Querol et al. · Haemophilia · 2000 · 130 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14